Hints and tips:
...BioNTech [also] doesn’t have any other products so it’s a lot of cash to have to pay,” said Christopher Sharp, an IP lawyer at Pinsent Masons....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...That pales in comparison with the 76 per cent of Americans able to connect to 5G and even higher rates in some parts of Asia, such as South Korea where it is 93 per cent, according to Analysys Mason research...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...AT&T, cigarette maker Philip Morris International and drugmaker Pfizer have also managed to lower their borrowing costs with recent debt issuance....
...We have Pfizer, we have Chiesi, we have [AstraZeneca] . . .[ and] Bohringer Ingelheim in this COPD space with huge amounts to offer and huge skin in the game.”...
...Stuart McNeill, partner at Pinsent Masons, said it was highly unusual that litigation from an insolvency case would go on for so long....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...The line up is: Portugal v Sweden, France v Ukraine, Greece v Romania and Iceland v Croatia PlayStation 4 launches Sony launches its PlayStation 4 in the US....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Others investigating their potential include Cellectis and Pfizer....
...One is Legg Mason Global Asset Management, New York, which manages $643bn from Baltimore, including $1.2bn in its Target Retirement fund series....
...Groupon, run by Andrew Mason, has taken in $500m of an expected $950m in its new round. With Facebook, Goldman is buying $375m in stock for itself and offering as much as $1.5bn to wealthy clients....
...Professor Chris Mason of University College London reflects the mood of many caught off guard by the announcement....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...“This is a huge vote of confidence for UK stem cell science,” said Chris Mason, professor of regenerative medicine at University College London....
...And we can now judge the government’s fundamental assertion in US v Microsoft....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...V.I. Lenin gloated that western businessmen would greedily sell Communists the very rope they would later be hanged with. He was right about the greed....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition